Clindamycin Therapy

Clindamycin Therapy is a pharmacotherapeutic intervention that involves the administration of the lincosamide antibiotic clindamycin to target Gram-positive and anaerobic pathogens in sepsis management, distinguished by its unique spectrum of antimicrobial activity and role in modulating toxin production in specific bacterial infections.

1.7K

Publications

78.9K

Citations

6.5K

Authors

1.8K

Institutions

Publications per year

2017–2026

224

Authors

6.5K

  1. JG
    John G. Bartlett

    Johns Hopkins University, United States

    14 publications · 2K citations

    13

    h-index

  2. PG
    Peter G. Kremsner

    University of Tübingen, Germany

    12 publications · 585 citations

    12

    h-index

  3. PC
    Peter C. Appelbaum

    Penn State Milton S. Hershey Medical Center, United States

    10 publications · 331 citations

    10

    h-index

  4. MD
    Maria D. Appleman

    University of Southern California, United States

    9 publications · 238 citations

    9

    h-index

  5. IB
    Itzhak Brook

    Georgetown University, United States

    9 publications · 365 citations

    9

    h-index

1–5 of 6.5K

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 178 publications · 8.2K citations

    52

    h-index

  2. PubMed

    Repository · 223 publications · 6.2K citations

    38

    h-index

  3. The Journal of Infectious Diseases

    JID · 55 publications · 4.3K citations

    36

    h-index

  4. Clinical Infectious Diseases

    CID · 57 publications · 5.1K citations

    35

    h-index

  5. Journal of Antimicrobial Chemotherapy

    JAC · 83 publications · 2.8K citations

    30

    h-index

1–5